Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Trial Policy meeting

This article was originally published in The Gray Sheet

Executive Summary

Medicare Coverage Advisory Committee (MCAC) will address CMS' reconsideration of the Clinical Trial Policy at a public meeting Dec. 13 in Baltimore. The policy, implemented in 2000, provides coverage of routine costs for Medicare beneficiaries enrolled in "qualified" clinical studies. CMS opened a national coverage decision in July to revise the policy in light of "changes to the clinical research landscape" (1"The Gray Sheet" Aug. 21, 2006, p. 9). A proposed decision is now expected by April 10, with a final decision due in July...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT024148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel